Loading: 100%
PLURISTEM THERAPEUTICS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker PSTIno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 171,001,251,501,752,00
datesClosing price (adj.)
13.10.20171.71
11.10.20171.89
04.10.20171.50
27.09.20171.55
20.09.20171.56
13.09.20171.35
06.09.20171.23
30.08.20171.18
23.08.20171.16
16.08.20171.19
09.08.20171.11
02.08.20171.15
26.07.20171.22
19.07.20171.18
12.07.20171.24
05.07.20171.28
27.06.20171.35
20.06.20171.32
13.06.20171.35
06.06.20171.39
30.05.20171.37
23.05.20171.41
16.05.20171.30
09.05.20171.32
02.05.20171.42
25.04.20171.46
18.04.20171.42
11.04.20171.48
04.04.20171.47
28.03.20171.19
21.03.20171.20
14.03.20171.15
07.03.20171.17
28.02.20171.14
21.02.20171.12
14.02.20171.10
07.02.20171.15
31.01.20171.11
24.01.20171.13
17.01.20171.55
10.01.20171.62
03.01.20171.45
27.12.20161.52
19.12.20161.53
12.12.20161.47
05.12.20161.55
28.11.20161.52
21.11.20161.56
14.11.20161.56
07.11.20161.58
31.10.20161.55
24.10.20161.52
17.10.20161.46
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
1.71n/a
Market Capitalisation
in million USD
137n/a
Enterprise Value
in million USD
105n/a
Common Shares Outstanding
as per Jun 30, 2016
80,268,999n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
79,547,989n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Pluristem Therapeutics Inc is a bio-therapeutics company. It is engaged in developing off-the-shelf allogeneic cell therapy products for treatment of ischemic & inflammatory, cardiovascular, orthopedic, pulmonary, hematological, & women\'s health diseases.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 32n/a
Receivables 0n/a
Total Current Assets 36n/a
PP&E 9n/a
Total Assets 46n/a
Accounts Payable 3n/a
Current Debt 0n/a
Total Current Liabilities 6n/a
Long-Term Debt 0n/a
Total Liabilities 8n/a
Total Equity 38n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital -1n/a
Operating Cash Flow -19n/a
Net Change in PP&E and Intangibles -2n/a
Investing Cash Flow 1n/a
Dividends Paid 0n/a
Financing Cash Flow 1n/a
Total Change in Cash -16n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 0.48n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 3.57n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.28n/a
Other Ratios
Current Ratio 616.4%n/a
Liabilities to Equity Ratio 20.4%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
0
0
1
1
0
0
3
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
0
0
1
1
0
0
3
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
14
19
28
43
53
49
49
Selling, General & Administrative
3
4
7
6
9
6
6
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
10
15
22
37
44
43
42
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
14
19
29
43
54
49
52
Non-Operating Income (Loss)
0
0
0
1
1
1
0
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
14
20
29
45
54
50
52
Abnormal Gains (Losses)
2
2
4
3
5
4
3
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
15
21
33
47
60
54
55
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
15
21
33
47
60
54
55
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
15
21
33
47
60
54
55
Minority Interest
0
0
0
0
0
0
0
Net Income
15
21
33
47
60
54
55
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
15
21
33
47
60
54
55
Remarks
restated on Sep 10, 2012 n/a
calculated values,
restated on Sep 11, 2013 n/a
calculated values,
restated on Sep 11, 2014 n/a
calculated values,
restated on Sep 9, 2015 n/a
calculated values,
restated on Sep 7, 2016 n/a
calculated values,
restated on Sep 7, 2016 n/a
calculated values,
restated on Sep 7, 2016 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
43
38
54
54
52
32
Cash & Cash Equivalents
n/a
43
9
9
4
23
6
Short Term Investments
n/a
0
28
45
49
29
26
Accounts & Notes Receivable
n/a
0
0
0
2
2
2
Accounts Receivable, Net
n/a
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
0
0
1
6
3
1
Prepaid Expenses
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
1
6
3
1
Total Current Assets
n/a
43
38
55
62
57
36
Property, Plant & Equipment, Net
n/a
2
2
12
11
10
9
Property, Plant & Equipment
n/a
0
2
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
1
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
1
1
1
1
1
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
1
1
1
1
1
Total Noncurrent Assets
n/a
3
4
13
12
11
10
Total Assets
n/a
46
42
68
74
68
46
Liabilities and owners' equity
Payables & Accruals
n/a
2 2018000
3 3167000
5 5149000
7 6771000
6 5711000
6 5775000
Accounts Payable
n/a
1 1177000
1 1368000
3 2837000
3 3465000
3 3268000
3 2705000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
1 841000
2 1799000
2 2312000
3 3306000
2 2443000
3 3070000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
2 2355000
1 772000
1 626000
0 472000
0 0
Deferred Revenue
n/a
0 0
1 779000
0 379000
0 379000
0 379000
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
2 1576000
0 393000
0 247000
0 93000
0 0
Total Current Liabilities
n/a
2 2018000
6 5522000
6 5921000
7 7397000
6 6183000
6 5775000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
1 576000
4 4156000
5 4929000
5 4503000
3 3039000
2 2010000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
4 3505000
3 3226000
3 2847000
2 2468000
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1 576000
1 651000
2 1703000
2 1656000
1 571000
2 2010000
Total Noncurrent Liabilities
n/a
1 576000
4 4156000
5 4929000
5 4503000
3 3039000
2 2010000
Total Liabilities
n/a
3 2594000
10 9678000
11 10850000
12 11900000
9 9222000
8 7785000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
94 94375000
104 103619000
144 144109000
173 172998000
195 195304000
198 198433000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-51 -50953000
-66 -65747000
-87 -86902000
-114 -113834000
-139 -138511000
-162 -161757000
Other Equity
n/a
0 0
0 -130000
0 259000
3 2959000
2 2140000
1 1480000
Equity Before Minority Interest
n/a
43 43422000
38 37742000
57 57466000
62 62123000
59 58933000
38 38156000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
43 43422000
38 37742000
57 57466000
62 62123000
59 58933000
38 38156000
Total Liabilities & Equity
n/a
46 46016000
47 47420000
68 68316000
74 74023000
68 68155000
46 45941000
Remarks restated on n/a restated on Sep 10, 2012 n/a restated on Sep 11, 2013 n/a restated on Sep 11, 2014 n/a restated on Sep 9, 2015 n/a restated on Sep 7, 2016 n/a restated on Sep 7, 2016 n/a
Cash Flow StatementCF data quality: 96% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-7
-11
-15
-21
-27
-25
-23
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
1
2
2
2
Non-Cash Items
2
3
5
3
7
5
3
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
0
1
6
0
-1
-3
-1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-5
-6
-3
-17
-19
-21
-19
Change in Fixed Assets & Intangibles
0
-1
-1
-4
-2
-1
-2
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
-7
-6
-4
6
4
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-1
1
-21
-10
7
16
-1
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-1
0
-30
-21
2
22
1
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
-1
1
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
6
47
1
36
13
17
1
Increase in Capital Stock
6
47
1
36
13
17
1
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
6
47
0
37
13
17
1
Net Cash Before Disc. Operations and FX
-1
41
-33
0
-5
18
-16
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-1
41
-33
0
-5
18
-16
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
-1
41
-33
0
-5
18
-16
Remarks
restated on Sep 10, 2012 n/a
calculated values,
restated on Sep 11, 2013 n/a
calculated values,
restated on Sep 11, 2014 n/a
calculated values,
restated on Sep 9, 2015 n/a
calculated values,
restated on Sep 7, 2016 n/a
calculated values,
restated on Sep 7, 2016 n/a
calculated values,
restated on Sep 7, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo